Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2014
09/18/2014US20140275118 Substituted 2-azabicycles and their use as orexin receptor modulators
09/18/2014US20140275111 Novel compounds as rearranged during transfection (ret) inhibitors
09/18/2014US20140275110 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/18/2014US20140275101 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
09/18/2014US20140275100 Pyridazine derivatives useful in therapy
09/18/2014US20140275095 Substituted piperidine compounds and their use as orexin receptor modulators
09/18/2014US20140275087 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275085 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014US20140275084 Histone demethylase inhibitors
09/18/2014US20140275080 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275079 Pyrrole amide inhibitors
09/18/2014US20140275077 Uracil derivatives as axl and c-met kinase inhibitors
09/18/2014US20140275075 Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
09/18/2014US20140275074 Heterocyclic derivative having pgd2 receptor antagonist activity
09/18/2014US20140275072 Morpholinylbenzotriazines for use in cancer therapy
09/18/2014US20140275061 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/18/2014US20140275060 Compounds for the treatment of neurologic disorders
09/18/2014US20140275057 Novel compounds and compositions for the inhibition of nampt
09/18/2014US20140275049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS
09/18/2014US20140275029 1,2,6-substituted benzimidazoles as flap modulators
09/18/2014US20140275028 1,2,5-substituted benzimidazoles as flap modulators
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275016 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275011 Pyridine cdk9 kinase inhibitors
09/18/2014US20140275008 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275006 Azole derivative
09/18/2014US20140275005 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/18/2014US20140275002 Azetidinyloxyphenylpyrrolidine compounds
09/18/2014US20140274961 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140274960 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/18/2014US20140273214 Stem cell cultures
09/18/2014US20140271662 Pyrazole derivatives as protein kinase modulators
09/18/2014US20140271591 Compositions and methods for the modulation of hemoglobin (s)
09/18/2014US20140271543 Pyridin-2(1h)-one derivatives as jak inhibitors
09/18/2014US20140271465 Matrix metalloprotease (mmp) targeted agents for imaging and therapy
09/17/2014EP2778161A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof
09/17/2014EP2778160A1 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component
09/17/2014EP2778159A1 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2778155A1 2-aminopyridine derivatives useful as kinase inhibitors
09/17/2014EP2776420A1 Pyrazine compounds useful as inhibitors of atr kinase
09/17/2014EP2776419A1 Pyrazine compounds useful as inhibitors of atr kinase
09/17/2014EP2776418A1 Inhibitors of phosphodiesterase type 10a
09/17/2014EP2776417A1 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
09/17/2014EP2776416A1 Pharmaceutical compounds
09/17/2014EP2776411A1 Modulators of c3a receptors
09/17/2014EP2776408A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
09/17/2014EP2776405A1 2-thiopyrimidinones
09/17/2014EP2776404A1 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/17/2014EP2776397A1 Quinolines as fgfr kinase modulators
09/17/2014EP2776396A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
09/17/2014EP2776387A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/16/2014US8835648 Hedgehog pathway antagonists and therapeutic applications thereof
09/16/2014US8835641 Fluorescent markers and use thereof for labeling specific protein targets
09/16/2014US8835640 Nicotine derivatives
09/16/2014US8835634 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/16/2014US8835633 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
09/16/2014US8835631 Therapeutic agent for cerebral infarction
09/16/2014US8835629 Anti-cancer agents
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835466 Synthesis and uses of pyroglutamic acid derivatives
09/16/2014US8835465 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
09/16/2014US8835464 Triazole compounds that modulate HSP90 activity
09/16/2014US8835463 Compounds having analgesic and/or immunostimulant activity
09/16/2014US8835461 Substituted 3-hydroxy-4-pyridone derivative
09/16/2014US8835457 Bridged bicyclic RHO kinase inhibitor compounds, compositions and use
09/16/2014US8835445 Dihydrofolate reductase inhibitors
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835439 Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseases
09/16/2014US8835437 Piperidine/piperazine derivatives
09/16/2014US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
09/16/2014US8835432 Heterocyclic compounds and their uses
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835426 Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/16/2014CA2750864C Bis-aryl amide compounds and methods of use
09/16/2014CA2653666C Aryl-substituted heterocycles and their use
09/16/2014CA2623202C Hydrazide compound and pesticidal use of the same
09/16/2014CA2604895C (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer
09/12/2014WO2014138616A2 Pyrazole compounds and methods of use thereof
09/12/2014WO2014138460A1 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors
09/12/2014WO2014138368A1 Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
09/12/2014WO2014138302A1 Quinazolinone antibiotics
09/12/2014WO2014138199A1 Pyrimidine compounds for the treatment of hepatitis c
09/12/2014WO2014138168A1 Processes and intermediates for making a jak inhibitor
09/12/2014WO2014138053A1 Neprilysin inhibitors
09/12/2014WO2014136860A1 Compound, luminescent material and organic luminescent element
09/12/2014WO2014136730A1 Oxidation reaction with excellent conversion rate
09/12/2014WO2014136075A1 H3 antagonists containing phenoxypiperidine core structure
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135588A1 Alkoximino-substituted anthranilic acid diamides as pesticides
09/12/2014WO2014135561A1 New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135483A1 Antiviral compounds
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 1080